Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Aug 17, 2026
Revenue (TTM)
$79.67B
+47.7% YoY
Gross margin
83.4%
EPS (latest q)
$8.38
vs $6.01 est · beat
52-wk position
90.3%
-4.3% vs 52w high · +0.2% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) holds a $1.05 trillion market capitalization, supported by a 47.7% year-over-year revenue increase and $79.67 billion in trailing twelve-month revenue. The firm reported $22.97 billion in revenue for the quarter ending June 30, 2026, extending a streak of four consecutive earnings beats. The company maintains an 83.4% gross margin and a 54.2% operating margin, with the stock price rising 15.7% over the past three months to $1180.16.
Valuation
- Market cap
- $1.05T
- P/E
- 39.68
- PEG
- 1.484
- P/B
- 31.05
- P/S
- 13.21
- EV/EBITDA
- 26.32
- Beta
- 0.506
- Analyst target
- $1310.9
Quality & returns
- Gross margin
- 83.4%
- Operating margin
- 54.2%
- Profit margin
- 33.5%
- ROE
- 102.3%
- ROA
- 20.4%
Price movement
- Last
- $1180.16
- 1-month
- +0.2%
- 3-month
- +15.7%
- RSI (14)
- 48
- vs SMA200
- +13.5%
- 52-wk position
- 90.3% -4.3% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $22.97B | $8.98B | $7.09B | $9.25B |
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.69B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
Recent news
- Somewhat-Bullish Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs · 2026-08-16
- Somewhat-Bullish MDGL Stock In Focus — Retail Traders Buzz Over M&A Speculation And Fresh Patents For Liver Drug · 2026-08-16
- Somewhat-Bullish Arista Networks Just Hit a Record High After Its First $3 Billion Quarter. Is It Too Late to Buy? · 2026-08-15
- Somewhat-Bullish Healthcare ETF Showdown: Fidelity's Diversified Fund Beats iShares on Cost and Risk · 2026-08-15
- Somewhat-Bullish Oppenheimer Asset Management Inc. Invests $49.62 Million in CVS Health Corporation $CVS · 2026-08-15
- Somewhat-Bullish GDOC Dividend: 0.31% Yield, $0.11/Share — History & Dates · 2026-08-15
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)